Literature DB >> 1961986

Causative factors of retinal detachment in macular holes.

H Morita1, H Ideta, K Ito, J Yonemoto, K Sasaki, S Tanaka.   

Abstract

Two hundred nine macular holes of both pathologic myopia and idiopathic senile type were statistically analyzed to find out which factors cause retinal detachment in eyes with macular holes. The incidences of retinal detachment were as follows: 97.6% in myopia over -8.25 D, 67.7% in myopia between -8.0 and -3.25 D, and 1.1% in eyes under -3.0 D; 100% in widespread chorioretinal atrophy, 90.6% in spotty or lineal chorioretinal atrophy, 64.3% in myopic tigroid fundus, and 0% in eyes without myopic tigroid or atrophy; 96.0% in eyes with posterior staphyloma and 8.2% in eyes without it; 56.4% in posterior vitreous detachment [PVD] (+) eyes, 53.3% in PVD(+/-) eyes, and 51.9% in PVD(-) eyes. The statistically significant (P less than 0.05) factors that caused retinal detachment were refractive error, myopic chorioretinal change, and posterior staphyloma. There was no statistically significant difference regarding PVD.

Entities:  

Mesh:

Year:  1991        PMID: 1961986     DOI: 10.1097/00006982-199111030-00002

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  33 in total

1.  1000 cSt silicone oil vs heavy silicone oil as intraocular tamponade in retinal detachment associated to myopic macular hole.

Authors:  Maurizio Mete; Barbara Parolini; Emilia Maggio; Grazia Pertile
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-16       Impact factor: 3.117

2.  Relation of posterior staphyloma in highly myopic eyes with macular hole and retinal detachment.

Authors:  Yoshinori Oie; Yasushi Ikuno; Takashi Fujikado; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

3.  Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia.

Authors:  Benson T O Cheung; Timothy Y Y Lai; Can Y F Yuen; Wico W K Lai; Chi-Wai Tsang; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

4.  Utility of microscope-integrated optical coherence tomography (MIOCT) in the treatment of myopic macular hole retinal detachment.

Authors:  Atul Kumar; Prateek Kakkar; Raghav Dinesh Ravani; Ashish Markan
Journal:  BMJ Case Rep       Date:  2017-07-14

5.  Co-existent choroidal neovascular membrane and macular hole in pathologic myopia: a long follow-up clinical outcome and literature review.

Authors:  Zhi-Qing Chen; Ji-Jian Lin; Pan-Pan Ye; Li Zhang; Xiao-Yun Fang
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

6.  Inverted internal limiting membrane insertion versus standard internal limiting membrane peeling for macular hole retinal detachment in high myopia: one-year study.

Authors:  Taku Wakabayashi; Yasushi Ikuno; Nobuhiko Shiraki; Nagakazu Matsumura; Hirokazu Sakaguchi; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-18       Impact factor: 3.117

7.  Epidemiologic characteristics of rhegmatogenous retinal detachment in Kumamoto, Japan.

Authors:  K Sasaki; H Ideta; J Yonemoto; S Tanaka; A Hirose; C Oka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

Review 8.  Recent trends in the management of maculopathy secondary to pathological myopia.

Authors:  D Mitry; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-13       Impact factor: 3.117

9.  Comparison of myopia progression between children wearing three types of orthokeratology lenses and children wearing single-vision spectacles.

Authors:  Yo Nakamura; Osamu Hieda; Isao Yokota; Satoshi Teramukai; Chie Sotozono; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2021-07-22       Impact factor: 2.447

10.  Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case-control study.

Authors:  A K H Kwok; T Y Y Lai
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.